Open AccessThe Worse the Skin Toxicity with EGFR Therapy, the More Promising the Outcome for Many Patients with Metastatic Colorectal Cancer
Author(s) -
Naomi Pfeiffer
Publication year - 2007
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000300447.78000.67
Subject(s) - cetuximab , panitumumab , medicine , rash , colorectal cancer , erlotinib , oncology , toxicity , cancer , adverse effect , kras , egfr inhibitors , epidermal growth factor receptor , quality of life (healthcare) , nursing